Autres langues EMV Capital plc

Actions

EMVC

GB00BN4R5Q82

Gestion des placements et exploitants de fonds

Marché Fermé - London S.E. Autres places de cotation 17:35:29 03/07/2026			Varia. 5j.	Varia. 1 janv.
51,50 ^GBX	0,00 %		0,00 %	-9,65 %

01/07	RÉSULTATS ET OPÉRATIONS : Home REIT prévoit de céder le reste de ses actifs d'ici fin juillet	AN
22/05	EMV Capital plc : l'auditeur exprime des doutes sur la continuité de l'exploitation	CI

Autres langues

01/07	EARNING AND TRADING: Home REIT to sell remaining holdings by end-July
22/05	EMV Capital plc Auditor Raises 'Going Concern' Doubt
19/05	EMV Capital "optimistic" after annual AuM and revenue growth
19/05	EMV Capital Adopts Phantom Carried Interest Scheme for Senior Executives
19/05	EMV Capital reports AUM grows to £112.5 million as at 31 December 2025
19/05	Earnings Flash (EMVC.L) EMV Capital PLC Reports FY25 Revenue GBP2.9M
19/05	EMV Capital plc Appoints Will Whitehorn OBE as Chairman of the Board of Directors
19/05	EMV Capital plc Reports Earnings Results for the Full Year Ended December 31, 2025
02/02	Hercules and Brave Bison win deals; B90 optimistic
02/02	EMV Capital says FY group revenue expected to grow 16% to £2.8 million
02/02	EMV Capital plc Provides Group Earnings Guidance for the Year Ending 31 December 2025
10/12	SpaceandPeople's Berlin deal; Futura in patent boost
10/12	Wanda Connected Health Systems Limited announced that it has received £0.86 million in funding from EMV Capital plc
24/11	EMV Capital names new finance chief, creates new role
24/11	EMV Capital CFO to Transition to Newly Created Portfolio CFO Role
24/11	EMV Capital plc Announces Chief Financial Officer Changes, Effective December 1, 2025
24/11	EMV Capital appoints Anesh Patel as group CFO
30/09/25	EARNINGS: Caledonian widens annual loss; Fair Oaks dividend unchanged
30/09/25	EMV Capital plc Reports Earnings Results for the Half Year Ended June 30, 2025
22/09/25	Mosman Oil and Gas receives "pivotal" bond approval
22/09/25	EMV Capital Unit to Buy Destiny Pharma Assets for GBP2 Million
22/09/25	EMV Capital announces asset purchase agreement with Destiny Pharma
22/09/25	EMV Capital plc acquired Certain Assets Relating to the Novel XF Drug Platform of Destiny Pharma plc for £2.475 million.
27/06/25	EMV Capital Portfolio Company Q-Bot Raises Funds, Converts Loans
27/06/25	Q-Bot Limited announced that it expects to receive £1 million in funding from EMV Capital plc